Haystack MRD | Search

Trials

50 participants · First posted Oct 10, 2025

Recruiting

NCT07120698

Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)

115 participants · First posted Aug 13, 2025

Recruiting

NCT05536505

Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC

180 participants · First posted Sep 13, 2022

Drugs

View all 598 →

Biotech

Approved

Blinatumomab(Blincyto)

Conditions: Precursor B-lymphoblastic leukaemia acute, Refractory B-cell precursor acute lymphoblastic leukemia +1 more

Rx

Biotech

Investigational

PA3-17

Manufacturer: PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Conditions: Relapsed or Refractory T-Lymphoblastic Leukemia/Lymphoma (R/R T-ALL/LBL)

MR3

Organizations

View all 161 →

MSD FRANCE

France

MSD KK

Japan

MSD K.K.

Japan

News

View all 799 →

5 months ago

City of Hope Launches Multi-Cancer Study of Quest Diagnostics' Haystack MRD Test Across 14 Sites

last year

Mass General Brigham Launches Clinical Trials for Haystack MRD ctDNA Test in Head and Neck and Skin Cancers

7 months ago